Skip to main content
BMJ Open logoLink to BMJ Open
. 2015 Jun 24;5(6):e007384. doi: 10.1136/bmjopen-2014-007384

Enduring health effects of asbestos use in Belgian industries: a record-linked cohort study of cause-specific mortality (2001–2009)

Laura Van den Borre 1, Patrick Deboosere 1
PMCID: PMC4480022  PMID: 26109114

Abstract

Objective

To investigate cause-specific mortality among asbestos workers and potentially exposed workers in Belgium and evaluate potential excess in mortality due to established and suspected asbestos-related diseases.

Design

This cohort study is based on an individual record linkage between the 1991 Belgian census and cause-specific mortality information for Flanders and Brussels (2001–2009).

Setting

Belgium (Flanders and Brussels region).

Participants

The study population consists of 1 397 699 male workers (18–65 years) with 72 074 deaths between 1 October 2001 and 31 December 2009. Using a classification of high-risk industries, mortality patterns between 2056 asbestos workers, 385 046 potentially exposed workers and the working population have been compared.

Outcome measures

Standardised mortality ratios (SMRs) and 95% CIs are calculated for manual and non-manual workers.

Results

Our findings show clear excess in asbestos-related mortality in the asbestos industry with SMRs for mesothelioma of 4071 (CI 2327 to 6611) among manual workers and of 4489 (CI 1458 to 10 476) among non-manual workers. Excess risks in asbestos-related mortality are also found in the chemical industry, the construction industry, the electrical generation and distribution industry, the basic metals manufacturing industry, the metal products manufacturing industry, the railroad industry, and the shipping industry. Oral cancer mortality is significantly higher for asbestos workers (SMR 383; CI 124 to 894), railroad workers (SMR 192; CI 112 to 308), shipping workers (SMR 172; CI 102 to 271) and construction workers (SMR 125; CI 100 to 153), indicating a possible association with occupational asbestos exposure. Workers in all four industries have elevated mortality rates for cancer of the mouth. Only construction workers experience significantly higher pharyngeal cancer mortality (SMR 151; CI 104 to 212).

Conclusions

The study identifies vulnerable groups of Belgian asbestos workers, demonstrating the current-day health repercussions of historical asbestos use. Results support the hypothesis of a possible association between the development of oral cancer and occupational asbestos exposure.

Keywords: OCCUPATIONAL & INDUSTRIAL MEDICINE, EPIDEMIOLOGY, PUBLIC HEALTH, Asbestos, Belgium, Mortality studies


Strengths and limitations of this study.

  • Mortality among Belgian workers is investigated using exhaustive census-linked cause-specific mortality data at the individual level.

  • The availability of a large national database allows the study of industries with a relatively small number of workers.

  • Asbestos exposure data is not available for Belgium and could not be included in this study. However, high-risk industries are selected based on an extensive literature review and the strong aetiological relation between mesothelioma and asbestos exposure. A further differentiation is made between manual and non-manual workers.

  • Occupational information is only available for one point in time. Workers exposed before the census date may have been included in the reference population (eg, job change) or may have left the active population (eg, health reasons). Potential confounders after the census date are not taken into account. Our results may underestimate the true influence of occupational asbestos exposure.

Introduction

Belgium has the fourth highest mesothelioma mortality rate in the world, after the UK, Australia and Italy. Since 2006, over 200 Belgians have died from mesothelioma each year.1 Mesothelioma is considered to be a potent and sensitive indicator of asbestos exposure,2 but further research on other asbestos-related diseases is imperative to understand the full extent of the asbestos problem in Belgium. This study focuses on the primary source of asbestos exposure: the workplace.

Asbestos minerals do not occur naturally in Belgium. With the start of one of Europe's largest asbestos companies, Eternit, in the early 1900s, Belgium rapidly became an important supplier of asbestos products. Large amounts of raw asbestos fibres were imported for manufacturing purposes since the 1930s.3 Belgian asbestos industries used a mix of different types of asbestos, usually consisting of 90–99% chrysotile and 10–1% crocidolite.4 The use of relatively small amounts of amosite has also been reported.5

Asbestos use culminated during the 1960s–1970s, with Belgium having the highest asbestos consumption level per capita in the world.6 Since then, overall exposure levels have gradually decreased as a result of private and public health control measures, including the mandatory use of dust masks and the installation of exhaust systems in the workplace.7 Airborne occupational exposure limits for asbestos were implemented in 1980 to control exposure intensity and duration.8 Nonetheless, these measures did not avert all fatal health effects due to asbestos exposure.

Despite declining asbestos exposure levels, occupational exposure in, for example, asbestos product manufacturing, shipbuilding and construction, remained relatively common until the end of the 1990s. Industrial asbestos use was reduced dramatically with a major ban on all asbestos types in 1998. Some exceptions for chrysotile products remained until 2001, when the use and transaction of all types of asbestos were finally banned.

The few Belgian studies on asbestos health risks in the workplace are based on industry findings, biomedical data or information delivered by victim compensation funds.4 5 9 10 Considering the typical long latency periods of asbestos-related diseases and most occupational asbestos research dating back to the 1960s–1970s, results may not reflect the true public health consequences of industrial asbestos use. Selection bias, differences in diagnostic criteria and low civil awareness of compensation measures, make the representativeness of these data sources questionable.

International studies on the health of asbestos workers focus mainly on well-established asbestos-related diseases, namely asbestosis, malignant mesothelioma and lung cancer. Recently, the International Agency for Research on Cancer has acknowledged a causal effect in the development of laryngeal and ovarian cancer.11 The association between asbestos exposure and several other malignancies remains controversial.

The present study investigates cause-specific mortality among asbestos workers and potentially exposed workers to evaluate potential excess in mortality due to established and suspected asbestos-related diseases. For the first time, mortality follow-up data and individual employment information for a large study population are available to determine the impact of asbestos exposure on Belgian male workers.

Methods

Study design

An anonymous record linkage has been performed between detailed occupational information from the 1991 Belgian census and cause-specific mortality data from 1 October 2001 to 31 December 2009. The record linkage was based on a primary link between the 1991 Belgian census, and registration records of all deaths and migrations between the census date (1 March 1991) and 31 December 2009. Then, cause-specific mortality information was derived from death certificates for the period 2001–2009 and added to the dataset. As a result, there is a 10-year time lag between occupational information and cause-specific mortality data.

Death certificates are not available for the 3 Belgian regions. The cause-specific mortality data only covers Flanders and the Brussels Capital Region, where the majority of Belgian asbestos firms were located.1 According to data from the Scientific Institute for Public Health, all-cause mortality in Flanders and Brussels accounts for 65% of all Belgian male deaths in 2003–2010. Approximately 80% of all male mesothelioma mortality occurs among Flemish and Brussels men.12

Based on the 1991 census, we have identified 1 537 805 occupationally active men (18–65 years) in Flanders and the Brussels Capital Region. Prior to 1 October 2001, 3.5% of these workers emigrated and 3.6% died. Owing to missing occupational information, 30 922 workers could not be classified.

The study investigates 72 074 deaths between 1 October 2001 and 31 December 2009, among a cohort of 1 397 699 Flemish and Brussels men with valid occupational information at the time of the 1991 census.

Classification of high-risk industries

The comprehensive character of the census data provides a snapshot of the occupational distribution. Consequently, the risks of persons who have been at least potentially exposed to asbestos can be compared with all other occupational groups. Information about exposure circumstances is not available. Because of the widespread use of asbestos fibres in Belgium, careful consideration is required to distinguish occupational asbestos exposure from environmental or secondary exposure. We have combined the distribution of mesothelioma deaths in Belgian industries with an extensive literature review to determine the industries most at risk of asbestos-related health effects.

Malignant mesothelioma mortality was used as a marker for asbestos exposure (Tenth Revision of the International Classification of Diseases, ICD-10 C45). This highly fatal cancer develops in the protective linings of the lungs, chest wall, abdomen and heart, and is caused almost exclusively by asbestos exposure. Even low levels of asbestos exposure can induce malignant mesothelioma.13 Industrial sectors with at least three mesothelioma deaths during the period 2001–2009 were selected using the Statistical Classification of Economic Activities in the European Community (NACE).

We have cross-referenced these findings with the published literature. An extensive review of international and national studies on occupational asbestos exposure was conducted to ascertain at least potential asbestos use in these industries. Databases PubMed and Unicat (Union Catalogue of Belgian Libraries) have been examined. Keywords included “occupation*”, “industr*”, “asbestos”, “health”, “mortality”, “Belg*”. Additional searches were conducted using the names of the selected industries. Only peer-reviewed articles and government documents were considered. We have made no restrictions in time or language. If industrial asbestos use was established in at least one of the studies, the industry was included in further analyses.

Finally, industries with at least three mesothelioma deaths in the period 2001–2009 and with conclusive evidence of asbestos use were considered as high-risk industries. Three broad categories can be distinguished. Table 1 presents detailed information on the activities of the analysed industries in each category. Category A includes workers in asbestos industries. Category B includes workers in industries with potential asbestos exposure. Category C consists of workers in all industries excluded from categories A or B.

Table 1.

Types of industrial activities, per category

Industry Industrial activity
(A)
 Asbestos industry Asbestos cement manufacturing
Asbestos products manufacturing
(B)
 Automotive industry Manufacture and assembly of car parts
Manufacture and assembly of motor cycle parts
Repair and maintenance
 Chemical industry Manufacture of basic chemicals
Manufacture of pesticides and other agrochemical products
Manufacture of paints and similar coatings
Manufacture of soap, cosmetics and detergents
Manufacture of other chemical products
Manufacture of man-made fibres
Manufacture of basic pharmaceutical products
 Construction General construction and demolition
Construction of buildings and utilities
Civil engineering: roads and water supply
Installation companies
Final construction work
 Electricity generation and distribution Electricity generation and distribution
 Electrotechnical products manufacturing Manufacture of electrical appliances
Assembly and installation of electrotechnical products
 Manufacture of basic metals Manufacture of basic iron, steel and ferroalloys
Manufacture of steel tubes, pipes and related fitting
Manufacture of other products of first processing of steel
Manufacture of basic non-ferrous metals
 Metal products manufacturing Casting of metal
Manufacture of fabricated metal products
Manufacture and assembly structural metal parts
Manufacture of boilers and reservoirs
Grinderies and other
 Railroad industry Railway carriage construction
Repair and maintenance
Activities related to railway transport
 Shipping industry Shipyards, ship repair and maintenance
Activities related to inland, maritime and short sea shipping
 Textile industry Wool, cotton and other
Carpet, felt and linoleum
Other activities
(C)
 Reference population All other workers

A further differentiation was made between manual workers and all other occupational types in high-risk industries. The 1991 census includes information on the type of performed labour: self-employed, blue-collar, white-collar, management, etc. We defined manual workers as blue-collar workers and self-employed persons.i

Table 2 provides an overview of the number of manual and non-manual workers per industry, together with all-cause mortality and mesothelioma mortality. Of 704 458 manual workers in 1991, 40% were active in high-risk industries. All other occupational types in these industries account for approximately 15% of all 693 241 non-manual workers.

Table 2.

Mesothelioma deaths and total number of deaths for manual and non-manual workers by industry

Manual workers
Non-manual workers
Total
Industry N M D N M D N M D
(A)
 Asbestos industry 1743 16 121 313 5 18 2056 21 139
(B)
 Automotive industry 52 789 8 1856 12 057 1 261 64 846 9 2417
 Chemical industry 21 875 14 957 18 647 4 882 40 522 18 1839
 Construction industry 100 297 48 5341 22 387 16 1333 122 684 64 6674
 Electricity generation and distribution 2164 6 133 4489 7 277 6653 13 410
 Electrotechnical products manufacturing 15 854 3 571 12 920 6 462 28 774 9 1033
 Manufacture of basic metals 17 174 11 748 5209 3 263 22 383 14 1011
 Metal products manufacturing 29 960 9 1211 6603 2 298 36 563 11 1509
 Railroad industry 10 840 7 467 12 352 3 547 23 192 10 1014
 Shipping industry 12 255 15 784 3380 1 204 15 635 16 988
 Textile industry 20 008 3 1043 3786 2 159 23 794 5 1202
(C)
 Reference population 1 010 597 249 53 838

D, number of overall deaths; M, number of mesothelioma deaths; N, number of workers.

It is important to bear in mind an undetermined level of asbestos exposure for all categories of workers. Questions on occupational history are not included in the 1991 census. Hence, this research design cannot consider exposure duration or exposure in previous workplaces. In addition, workers may have been exposed to asbestos via the environment or through indirect contact.

Data analysis

Analyses are performed separately for manual and non-manual workers. Standardised mortality rates (SMRs) are calculated by 5-year age group with reference to workers in all other industries (category C). Lower and upper 95% CI are computed assuming that the observed deaths are Poisson variates. If the observed number of deaths is less than 100, exact limits are calculated directly from the Poisson distribution. For larger numbers, we use the Byar approximation method.14

Data for the study period 2001–2009 are combined because of the small number of cases per year for some of the industries under investigation. Analyses are based on the underlying cause of death as recorded on the death certificate. Cause-specific mortality is coded using the ICD-10.

Results

A total of 996 men died due to mesothelioma from 2001 through 2009. Although previous occupational asbestos exposure is possible, 545 mesothelioma deaths in the non-active population have been discarded from the classification process. One hundred and ninety-four deaths occurred among 173 137 men past the retirement age of 65 years in 1991, and 351 deaths occurred among 510 681 non-active men aged 18–65 years. The selection of high-risk industries is based on a total of 439 mesothelioma deaths in the active population (n=1 397 699).

Table 3 compares mesothelioma and all-cause mortality in the active and non-active population for men at working ages in 1991. From 2001 to 2009, 21 asbestos workers and 169 potentially exposed workers died due to mesothelioma. Two hundred and forty-nine mesothelioma deaths occurred in the reference population. The high overall mortality among non-active men before age 65 years indicates a “healthy worker effect”. Healthy workers remain in the workforce whereas persons with health problems are more inclined to quit prematurely. We restrict further analysis to the active population in 1991.

Table 3.

Mesothelioma and all-cause mortality in 2001–2009 by activity status for men aged 18–65 years in 1991*

Mesothelioma
Overall
Characteristics N O SMR (CI) O SMR (CI)
Active population
 Asbestos workers 2056 21 2890 (1789 to 4417) 139 116 (97 to 136)
 Potentially exposed workers 385 046 169 141 (121 to 164) 18 097 88 (87 to 90)
 All other workers 1 010 597 249 68 (60 to 78) 53 838 85 (84 to 86)
 Missing information 30 922 12 103 (53 to 180) 2460 118 (114 to 123)
Non-active population
 Pre-retirement 190 090 265 115 (101 to 130) 52 575 108 (108 to 109)
 Unemployed 86 131 45 130 (95 to 175) 9012 148 (145 to 151)
 Disabled 25 046 25 140 (91 to 207) 6220 194 (189 to 198)
 Students 119 742 0 0 (0 to 1678) 642 65 (59 to 69)
 Other 30 734 2 59 (7 to 214) 1241 152 (143 to 160)
 Missing information 58 938 14 71 (39 to 119) 4912 136 (132 to 139)

*Reference population: Flemish and Brussels men (18–65 years).

N, number of men; O, observed number of deaths; SMR, standardised mortality ratio.

The results on asbestos-related mortality among asbestos workers and potentially exposed workers are presented in table 4, with the SMRs and 95% CIs by occupational type for the period 2001–2009.

Table 4.

Overall and asbestos-related mortality in selected industries for manual and non-manual workers*

  Asbestos industry
Chemical industry
Construction industry
Electrical generation and distribution industry
Manual
Non-manual
Manual
Non-manual
Manual
Non-manual
Manual
Non-manual
O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI
All deaths 121 150 125 to 180 18 80 47 to 126 957 97 91 to 103 882 80 75 to 86 5341 119 116 to 122 1333 100 95 to 106 133 98 82 to 116 277 87 77 to 98
All neoplasms 61 174 133 to 223 13 129 68 to 220 416 97 88 to 107 416 86 78 to 95 2399 125 120 to 130 602 105 97 to 114 75 122 96 to 153 131 91 76 to 108
Laryngeal cancer 1 182 5 to 1015 2 1425 173 to 5148 4 60 16 to 155 11 153 76 to 274 61 203 155 to 260 8 95 41 to 187 0 0 0 to 326 2 95 12 to 344
Lung cancer 21 175 108 to 268 1 29 1 to 161 151 103 88 to 121 110 67 55 to 81 995 153 144 to 163 200 104 90 to 119 25 118 76 to 174 33 66 46 to 93
Mesothelioma 16 4071 2327 to 6611 5 4489 1458 to 10 476 14 293 160 to 492 4 75 21 to 193 48 227 168 to 302 16 260 149 to 422 6 863 317 to 1878 7 430 173 to 885
Asbestosis 0 0 0 to 21 850 0 0 0 to 59 137 0 0 0 to 1809 0 0 0 to 1487 3 401 83 to 1171 2 843 102 to 3043 0 0 0 to 11 166 0 0 0 to 4692
  Manufacture of basic metals
Metal products manufacturing
Railroad industry
Shipping industry
Manual
Non-manual
Manual
Non-manual
Manual
Non-manual
Manual
Non-manual
O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI
All deaths 748 101 94 to 109 263 81 72 to 92 1211 114 108 to 121 298 84 75 to 94 467 112 102 to 122 547 99 91 to 108 784 124 116 to 133 204 94 82 to 108
All neoplasms 328 100 90 to 112 127 87 72 to 103 498 113 103 to 123 134 87 73 to 103 226 126 110 to 143 223 93 81 to 105 338 121 108 to 134 95 100 81 to 122
Laryngeal cancer 3 54 11 to 158 3 133 27 to 388 12 163 84 to 285 1 42 1 to 235 7 206 83 to 424 4 93 25 to 238 5 113 37 to 264 0 0 0 to 216
Lung cancer 127 112 94 to 134 29 57 38 to 82 203 138 119 to 158 47 90 66 to 119 74 122 96 to 153 78 95 75 to 118 136 141 119 to 167 34 106 73 to 147
Mesothelioma 11 291 145 to 520 3 178 37 to 522 9 187 85 to 354 2 118 14 to 425 7 352 141 to 725 3 112 23 to 327 15 475 266 to 784 1 97 2 to 540
Asbestosis 0 0 0 to 3205 0 0 0 to 5046 1 710 18 to 3957 1 1654 42 to 9217 0 0 0 to 6301 0 0 0 to 4079 0 0 0 to 2773 0 0 0 to 7192

*Reference population: manual and non-manual workers in all other industries.

O, observed number of deaths; SMR, standardised mortality ratio.

Asbestos-related mortality

Asbestos workers

Mesothelioma mortality is over 40 times higher among manual workers in the asbestos industry than among all other workers (SMR 4071; CI 2327 to 6611). Manual workers also experience 75% more lung cancer deaths than expected (SMR 175; CI 108 to 268). Results on laryngeal cancer mortality are inconclusive, as the ratio is based on only one observed death. No asbestosis deaths occurred among manual workers during the period 2001–2009.

We also find significant excess in asbestos-related mortality for jobs that do not involve direct contact with asbestos fibres. Non-manual workers in the asbestos industry have 45 times higher mesothelioma mortality than expected (SMR 4489; CI 1458 to 10 476). Laryngeal cancer mortality is almost 15 times higher than expected (SMR 1425; CI 173 to 5148). Contrary to their colleagues in manual labour jobs, non-manual workers do not seem to experience higher lung cancer mortality (SMR 29; CI 1 to 161).

Potentially exposed workers

Workers from the automotive industry, the electrical products manufacturing industry and the textile industry do not seem to experience significant excess in mortality due to asbestos-related diseases (not shown in table 4).

Mesothelioma mortality is significantly higher among manual workers in the electrical generation and distribution industry (SMR 863; CI 317 to 1878), shipping industry (SMR 475; CI 266 to 784), railroad industry (SMR 352; CI 141 to 725), chemical industry (SMR 293; CI 160 to 492), basic metals manufacturing industry (SMR 291; CI 145 to 520) and the construction industry (SMR 227; CI 168 to 302). Manual workers in the metal products manufacturing industry have a SMR of 187 (CI 85 to 354).

Lung cancer deaths are significantly higher than expected among construction workers (SMR 153; CI 144 to 163), shipping workers (SMR 141; CI 119 to 167) and metal products manufacturing workers (SMR 138; CI 119 to 158) in manual labour jobs.

With regard to laryngeal cancer mortality, observed deaths among manual workers in the construction industry are twice as high as expected (SMR 203; CI 155 to 260).

Among all potentially exposed workers in manual labour, four cases of asbestosis deaths have been recorded. Three deaths occurred among construction workers, resulting in an elevated SMR for asbestosis (SMR 401; CI 83 to 1171). One worker in metal products manufacturing died due to asbestosis.

The results for non-manual workers show significant excess in asbestos-related mortality in two industries with potential asbestos exposure. We find significant excess in mesothelioma mortality and asbestosis mortality in the construction industry with SMRs of 260 (CI 149 to 422) and 843 (CI 102 to 3043), respectively. Mesothelioma mortality is more than four times higher among non-manual workers in the electricity generation and distribution industry (SMR 430; CI 173 to 885).

Electricity generation and distribution is also one of three industries with a significant deficit in lung cancer mortality for non-manual workers (SMR 66; CI 46 to 93). The SMRs for lung cancer in the chemical industry and the basic metal manufacturing industry are 67 (CI 55 to 81) and 57 (CI 38 to 82), respectively.

Other causes of death

Table 5 presents the number of deaths from other causes by industry and occupational type, with the corresponding SMRs and 95% CIs. Results indicate significantly more oral cancer deaths among manual workers in the asbestos industry, railroad industry, shipping industry and the construction industry. When examining more closely, high oral cancer mortality is driven by excess deaths due to cancers of the mouth (ICD-10 C01-C06) in all four industries. Mouth cancer mortality is nine times higher among asbestos workers (SMR 938; CI 305 to 2189). Railroad workers experience about four times more mouth cancer deaths (SMR 390; CI 213 to 655). Shipping workers have an elevated SMR of 211 (CI 96 to 400). Construction workers experience 40% more mouth cancer deaths than expected (SMR 140; CI 101 to 189). For construction workers, we also find significant excess in pharyngeal cancer mortality (SMR 151; CI 104 to 212).

Table 5.

Overall and cause-specific mortality in selected industries for manual and non-manual workers*

  Asbestos industry
Chemical industry
Construction industry
Electrical generation and distribution industry
Manual
Non-manual
Manual
Non-manual
Manual
Non-manual
Manual
Non-manual
O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI
All deaths 121 150 125 to 180 18 80 47 to 126 957 97 91 to 103 882 80 75 to 86 5341 119 116 to 122 1333 100 95 to 106 133 98 82 to 116 277 87 77 to 98
All neoplasms 61 174 133 to 223 13 129 68 to 220 416 97 88 to 107 416 86 78 to 95 2399 125 120 to 130 602 105 97 to 114 75 122 96 to 153 131 91 76 to 108
Malignant head and neck 6 315 115 to 685 2 436 53 to 1576 19 82 50 to 129 18 74 44 to 117 155 148 126 to 173 32 114 78 to 160 2 64 8 to 233 6 86 32 to 187
Oral cancer 5 383 124 to 894 0 0 0 to 985 15 95 53 to 157 7 43 17 to 88 89 125 100 to 153 22 116 73 to 176 2 95 12 to 344 4 86 23 to 219
Mouth 5 938 305 to 2189 0 0 0 to 2351 5 77 25 to 180 3 44 9 to 129 42 140 101 to 189 9 114 52 to 216 0 0 0 to 352 1 52 1 to 287
Pharynx 0 0 0 to 751 0 0 0 to 2993 3 62 13 to 181 4 73 20 to 187 33 151 104 to 212 7 110 44 to 227 1 164 4 to 912 2 128 15 to 462
Other head and neck 0 0 0 to 5637 0 0 0 to 21 873 0 0 0 to 469 0 0 0 to 431 5 168 55 to 393 2 244 30 to 883 0 0 0 to 3440 0 0 0 to 1516
Malignant digestive system 7 76 31 to 157 1 38 1 to 209 110 98 80 to 118 119 94 78 to 112 561 111 102 to 121 140 93 78 to 109 17 105 61 to 169 36 95 67 to 132
Oesophageal cancer 2 128 16 to 463 0 0 0 to 739 18 95 56 to 150 22 107 67 to 162 112 131 108 to 158 18 75 44 to 118 2 76 9 to 275 9 149 68 to 284
Stomach cancer 1 84 2 to 471 0 0 0 to 899 17 117 68 to 188 10 63 30 to 115 77 118 93 to 148 24 127 81 to 189 4 197 54 to 504 1 21 1 to 118
Colon cancer 1 38 1 to 214 0 0 0 to 380 33 104 71 to 146 32 87 59 to 123 152 106 90 to 125 33 75 51 to 105 2 43 5 to 156 13 118 63 to 202
Rectal cancer 2 226 27 to 818 0 0 0 to 1168 13 121 64 to 206 12 99 51 to 173 58 121 92 to 157 19 133 80 to 208 3 192 40 to 562 2 55 7 to 197
Liver cancer 0 0 0 to 290 0 0 0 to 984 9 72 33 to 136 14 98 54 to 165 53 94 70 to 123 13 77 41 to 131 2 109 13 to 393 3 70 14 to 203
Pancreas cancer 1 54 1 to 298 1 183 5 to 1020 18 79 47 to 125 28 108 72 to 156 101 99 80 to 120 31 100 68 to 142 4 122 33 to 312 8 104 45 to 204
Other digestive 0 0 0 to 3427 0 0 0 to 10 249 2 186 23 to 673 1 72 2 to 402 8 160 69 to 314 2 114 14 to 411 0 0 0 to 1864 0 0 0 to 763
Malignant urogenital system 6 159 58 to 346 2 163 20 to 590 38 82 58 to 113 48 86 63 to 113 216 103 90 to 118 65 94 73 to 120 10 144 69 to 264 19 113 68 to 177
Prostate cancer 3 175 36 to 511 0 0 0 to 498 18 85 51 to 135 27 99 66 to 145 98 101 82 to 123 28 82 55 to 119 5 153 50 to 357 8 100 43 to 196
Testicular cancer 0 0 0 to 13 840 0 0 0 to 92 164 0 0 0 to 1140 0 0 0 to 1726 3 203 42 to 594 2 683 83 to 2469 0 0 0 to 13 444 0 0 0 to 7289
Bladder cancer 1 103 3 to 573 1 322 8 to 1792 10 85 41 to 156 10 70 34 to 129 64 120 92 to 153 17 99 57 to 158 2 111 13 to 402 4 92 25 to 237
Kidney cancer 2 188 23 to 680 1 324 8 to 1806 10 77 37 to 142 11 76 38 to 135 51 88 66 to 116 18 105 62 to 166 3 160 33 to 468 7 160 64 to 329
Non-neoplasms 48 130 96 to 173 4 36 10 to 93 430 95 86 to 105 401 76 69 to 84 2313 112 107 to 116 607 94 87 to 102 51 80 59 to 105 127 84 70 to 100
Circulatory system 27 131 86 to 191 2 32 4 to 117 238 94 83 to 107 230 78 68 to 89 1298 113 107 to 119 360 100 90 to 110 31 86 58 to 122 74 87 68 to 109
Respiratory system 10 238 114 to 437 1 70 2 to 391 46 89 65 to 119 36 56 39 to 77 279 118 104 to 132 74 91 72 to 114 4 51 14 to 131 18 95 56 to 150
Other diseases 11 91 46 to 163 1 30 1 to 166 146 99 83 to 116 135 81 68 to 96 736 108 101 to 116 173 85 73 to 99 16 80 45 to 129 35 75 52 to 104
External code 12 141 73 to 247 1 64 2 to 357 111 104 86 to 125 65 71 55 to 91 629 127 118 to 138 124 111 93 to 133 7 66 27 to 137 19 87 52 to 135
  Manufacture of basic metals
Metal products manufacturing
Railroad industry
Shipping industry
Manual
Non-manual
Manual
Non-manual
Manual
Non-manual
Manual
Non-manual
O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI O SMR CI
All deaths 748 101 94 to 109 263 81 72 to 92 1211 114 108 to 121 298 84 75 to 94 467 112 102 to 122 547 99 91 to 108 784 124 116 to 133 204 94 82 to 108
All neoplasms 328 100 90 to 112 127 87 72 to 103 498 113 103 to 123 134 87 73 to 103 226 126 110 to 143 223 93 81 to 105 338 121 108 to 134 95 100 81 to 122
Malignant head and neck 9 46 21 to 87 8 104 45 to 206 37 141 99 to 194 3 37 8 to 109 25 199 128 to 293 16 102 59 to 166 23 150 95 to 225 2 43 5 to 156
Oral cancer 6 44 16 to 96 5 96 31 to 225 24 132 85 to 196 2 37 4 to 132 17 192 112 to 308 12 110 57 to 192 18 172 102 to 271 1 32 1 to 179
Mouth 3 54 11 to 158 3 139 29 to 407 11 148 74 to 264 2 88 11 to 317 14 390 213 to 655 5 111 36 to 258 9 211 96 to 400 1 77 2 to 429
Pharynx 2 51 6 to 184 1 57 1 to 317 9 155 71 to 295 0 0 0 to 162 2 71 9 to 255 1 27 1 to 150 5 157 51 to 367 0 0 0 to 288
Other head and neck 0 0 0 to 588 0 0 0 to 1410 1 137 3 to 766 0 0 0 to 1302 1 285 7 to 1589 0 0 0 to 700 0 0 0 to 706 1 741 19 to 4131
Malignant digestive system 87 102 81 to 125 39 101 72 to 138 100 87 71 to 106 40 99 70 to 134 46 98 72 to 131 58 92 70 to 119 74 101 79 to 126 19 76 46 to 119
Oesophageal cancer 16 103 59 to 168 5 78 25 to 183 22 107 67 to 162 5 74 24 to 174 10 106 51 to 196 11 91 45 to 163 14 112 61 to 187 2 50 6 to 181
Stomach cancer 12 109 56 to 191 3 62 13 to 182 22 145 91 to 220 4 78 21 to 201 6 98 36 to 213 5 61 20 to 143 12 128 66 to 223 3 96 20 to 280
Colon cancer 20 86 52 to 132 15 136 76 to 225 25 79 51 to 117 14 121 66 to 202 10 82 39 to 151 21 124 77 to 190 24 116 74 to 172 7 96 39 to 198
Rectal cancer 13 158 84 to 270 1 27 1 to 148 6 55 20 to 120 5 129 42 to 301 5 117 38 to 273 3 52 11 to 151 6 85 31 to 186 1 42 1 to 235
Liver cancer 7 74 30 to 152 4 91 25 to 234 10 79 38 to 145 1 22 1 to 122 5 96 31 to 225 6 85 31 to 186 5 60 20 to 141 3 106 22 to 311
Pancreas cancer 18 105 62 to 165 11 140 70 to 250 15 65 36 to 107 11 133 66 to 238 10 106 51 to 196 11 87 43 to 156 13 87 46 to 149 3 59 12 to 172
Other digestive 1 134 3 to 744 0 0 0 to 778 0 0 0 to 281 0 0 0 to 693 0 0 0 to 757 1 179 5 to 999 0 0 0 to 425 0 0 0 to 1074
Malignant urogenital system 26 80 52 to 117 19 116 70 to 181 48 108 80 to 143 16 91 52 to 148 24 147 94 to 218 23 97 62 to 146 40 132 94 to 180 13 115 61 to 197
Prostate cancer 14 100 55 to 169 5 65 21 to 153 19 98 59 to 152 9 108 49 to 205 6 90 33 to 195 10 98 47 to 181 28 203 135 to 293 8 145 63 to 285
Testicular cancer 0 0 0 to 1621 0 0 0 to 7102 0 0 0 to 604 0 0 0 to 4339 0 0 0 to 3023 0 0 0 to 2645 0 0 0 to 2329 0 0 0 to 8691
Bladder cancer 6 70 26 to 152 5 117 38 to 273 10 88 42 to 162 4 89 24 to 229 9 210 96 to 398 2 32 4 to 117 7 90 36 to 185 3 105 22 to 308
Kidney cancer 6 61 22 to 132 9 202 92 to 383 19 145 88 to 227 3 65 13 to 190 9 171 78 to 325 11 153 77 to 274 5 59 19 to 137 2 70 8 to 253
Non-neoplasms 325 99 88 to 110 111 73 60 to 88 528 112 103 to 122 139 83 70 to 98 195 104 90 to 120 260 103 91 to 117 354 121 109 to 134 92 88 71 to 108
Circulatory system 184 100 86 to 115 68 79 62 to 100 290 112 99 to 125 84 90 71 to 111 120 116 96 to 139 155 111 94 to 129 195 119 103 to 137 53 90 68 to 118
Respiratory system 52 150 112 to 197 12 66 34 to 115 68 139 108 to 176 14 70 38 to 117 27 154 101 to 224 24 93 59 to 138 45 134 97 to 179 8 61 26 to 120
Other diseases 89 80 65 to 99 31 65 44 to 92 170 105 90 to 122 41 76 55 to 104 48 73 54 to 97 81 94 75 to 117 114 120 99 to 144 31 95 64 to 135
External cod 95 115 93 to 141 25 100 64 to 147 185 126 108 to 145 25 77 50 to 114 46 89 65 to 119 64 108 84 to 139 92 155 125 to 190 17 102 59 to 163

*Reference population: manual and non-manual workers in all other industries.

O, observed number of deaths; SMR, standardised mortality ratio.

Significant excess in mortality is found for two other types of malignancies. The SMR for oesophageal cancer mortality among construction workers in manual labour jobs equals 131 (CI 108 to 158). Prostate cancer deaths are two times higher among manual workers in shipping (SMR 203; CI 135 to 293).

Findings also indicate elevated mortality due to diseases of the circulatory system for manual workers in six industries: the asbestos industry, construction industry, basic metals manufacturing industry, metal products manufacturing industry, railroad industry and the shipping industry. Looking at the circulatory diseases separately, we find asbestos workers experience a higher number of deaths caused by cerebrovascular disease (SMR 200; CI 80 to 411) (not shown in table 5). Mortality due to ischaemic heart disease is significantly higher among construction workers (SMR 118; CI 109 to 127), shipping workers (SMR 124; CI 100 to 151) and railroad workers (SMR 132; CI 102 to 169) (not shown in table 5).

For mortality due to respiratory diseases, we find elevated SMRs for manual workers in the asbestos industry, construction industry, basic metals manufacturing industry, metal products manufacturing industry, railroad industry and the shipping industry. This is due to relatively high numbers of deaths from chronic obstructive pulmonary diseases (COPD). Mortality due to COPD is significantly higher for construction workers (SMR 127; CI 109 to 147), basic metals manufacturing workers (SMR 166; CI 116 to 230), metal products manufacturing workers (SMR 172; CI 128 to 226) and shipping industry workers (SMR 176; CI 124 to 243) (not shown in table 5). In addition to elevated mortality due to COPD (SMR 228; CI 84 to 496), results for asbestos workers indicate higher pneumonia mortality (SMR 336; CI 91 to 859) (not shown in table 5).

Construction workers in manual labour jobs experience excess mortality due to other diseases, because of a significantly higher number of deaths from alcoholic liver disease (SMR 138; CI 115 to 164, not shown in table 5).

Discussion

Cause-specific mortality among high-risk workers and all other workers is compared to determine the current impact of asbestos exposure on Belgian workers’ mortality. In addition to asbestos workers, 10 types of industrial workers are identified as potentially exposed. Results indicate significant excess in asbestos-related mortality in the asbestos industry and in seven of the selected industries, those being, the chemical industry, construction industry, electrical generation and distribution industry, basic metals manufacturing industry, metal products manufacturing industry, railroad industry and the shipping industry. Contrary to other reports,15–21 we did not find significant excess risks for asbestos-related mortality in the automotive industry, textile industry or in the electrotechnical industry.

Results clearly show a very high impact of asbestos exposure on asbestos workers. Mesothelioma mortality is 41 times higher among manual workers and 45 times higher among non-manual workers than in the reference population. Significant excess in laryngeal cancer and lung cancer mortality is found for non-manual workers and manual workers, respectively. Working in the asbestos industry seems to entail serious asbestos-related health risks, regardless of the occupational type. It is likely that asbestos exposure in this industry is not confined to specific work-related tasks, but also includes site-related environmental exposure.

Among potentially exposed workers, significant excess in mesothelioma mortality is found for manual work in the chemical industry, the basic metal manufacturing industry and the railroad industry. Surprisingly, manual and non-manual workers in the electricity generation and distribution industry both have a significantly higher number of mesothelioma deaths. This may indicate more widespread asbestos exposure in this industry than expected.

Shipping industry workers in manual labour jobs experience significantly higher mesothelioma and lung cancer mortality. Results also show increased mortality risks for mesothelioma and lung cancer among manual workers in metal products manufacturing, with significant excess in lung cancer deaths.

The construction industry is the only industry with elevated SMRs for all four established asbestos-related diseases. In addition to manual workers, non-manual workers in the construction industry experience significantly higher numbers of mesothelioma and asbestosis deaths. An underestimation of asbestosis mortality is possible because asbestosis is frequently coded as a contributing cause of death, and this study is based on underlying causes of death.

Cause-specific mortality is further scrutinised to identify additional excess in mortality among high-risk workers and evaluate a potential association with asbestos exposure. The results for four industries corroborate a possible association between asbestos exposure and the development of oral cancer. Manual workers in the asbestos industry, construction industry, shipping industry and the railroad industry have significantly higher oral cancer mortality. Tobacco and alcohol consumption are considered to be major risk factors.22 However, occupational asbestos exposure has also been reported as a possible causal factor for oral cancer types,23–25 and for pharyngeal cancer.26 Historical exposure circumstances should be explored further in order to answer why, specifically, these workers experience high oral cancer mortality.

Reports of elevated prostate cancer risks related to occupational asbestos exposure are scarce.27 28 Krstev et al29 found significant excess prostate cancer mortality among unexposed shipping workers. Therefore, a causal effect of asbestos exposure is doubtful.

Potential confounding factors for laryngeal cancer are smoking and alcohol use. Tobacco consumption, a major risk factor for lung cancer, could even have a multiplicative effect when combined with asbestos.30 31 Considering the use of various carcinogens such as nickel, cadmium or PAHs in the selected industries, concomitant occupational exposure is highly likely. Because of insufficient data, potential confounders could not be considered in our analyses. Results do show that manual workers in construction, in basic metal manufacturing, in metal products manufacturing and in shipping, have significantly higher mortality due to COPD, which is known to be caused predominantly by smoking. Occupational exposure to dust, fumes and gases has been associated with increased incidence of COPD.32 Construction workers also experience significant excess in mortality due to alcoholic liver disease, oesophageal cancer, mouth cancer and pharyngeal cancer, suggesting high alcohol use. Although mesothelioma and asbestosis mortality provides clear indications of considerable asbestos-related health effects in these industries, further research is needed to estimate the effect of asbestos exposure on lung cancer and laryngeal cancer mortality.

The main advantage of this study is the availability of census-linked, cause-specific mortality data. The anonymous linkage at the individual level minimises the nominator-denominator bias. Furthermore, even industries with relatively small working populations could be included in this study, due to the large number of persons in the data set.

The study design has some limitations. Occupational information is only available for a specific time period. Our findings may be confounded by exposure during previous jobs. Persons who have already quit asbestos-related industries at the time of the 1991 census cannot be identified. The most heavily exposed workers may have already left the workforce due to health reasons. As only actively employed workers are studied, healthy worker effects may bias our results. Based on the number of mesothelioma deaths among pre-retired men in the non-active population, we believe that a considerable proportion of occupational asbestos victims remain unnoticed.

As a result of job changes prior to the census date, it is also possible that occupationally exposed workers are included in the reference population. Although workers in the reference population are at least partially exposed to asbestos in the environment or through indirect contact, the number of mesothelioma deaths is larger than anticipated. As recent studies estimate that 8.3% to 11% of all mesothelioma deaths are attributable to non-occupational asbestos exposure,33 34 our results may still underestimate the true influence of occupational asbestos exposure.

Occupational information after the 1991 census is not available. Hence, potential confounders related to the last job have not been taken into account. Owing to the long period between asbestos exposure and onset of related diseases, we believe this does not alter the interpretation of our results.

Assumptions on asbestos exposure are industry-based. Although occupational type is considered, individual exposure information is not available and the number of workers at risk is surely overestimated. It is possible that asbestos exposure occurs in some industries only among specific groups of workers at specific workstations, and the effect of occupational asbestos exposure remains unnoticed. This may explain why no significant effects were found for asbestos-related mortality in the automotive industry, the textile industry and the electrotechnical industry.

The distinction between manual and non-manual workers is based on the physical or intellectual nature of the work, as stated in the labour agreement between employer and employee. This criterion is highly subject to interpretation. Reports have been made of workers doing the same job, but with different statuses (blue-collar vs white-collar status).35 36

In conclusion, cause-specific mortality reveals the repercussions of historical asbestos use on Belgian workers. Asbestos workers are not the only employees to experience increased asbestos-related mortality. The study also identifies eight industries with significantly elevated asbestos-related mortality, which have been previously overlooked in Belgian asbestos research. Furthermore, observations in four industries indicate a possible association between occupational asbestos exposure and the development of oral cancer. This study contributes to the large amount of international evidence on the adverse health effects of occupational asbestos exposure. Workers should be informed about the risks of past exposure and all forms of asbestos use should be banned.

Acknowledgments

The authors thank Didier Willaert for his much-appreciated help in preparing the data and Jan De Schampheleire for his expert advice on the Belgian labour market.

Contributors: PD and LVdB designed the study. LVdB conducted the study and wrote the first draft of the manuscript. Both authors edited the draft, discussed the interpretation and approved the final version of the manuscript.

Funding: The Research Council of Vrije Universiteit Brussel supported the study. LVdB is a PhD fellow at the Research Foundation-Flanders (FWO). Preliminary results were presented at the 2014 European Population Conference and the XX World Congress on Safety and Health at Work.

Competing interests: None declared.

Ethics approval: The Belgian Commission for the protection of privacy.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data sharing statement: Analyses are based on administrative data from the Belgian Census, the Belgian mortality register and death certificates provided by Statistics Belgium. The availability of the data is restricted. Permission for analyses must be granted after verification of the research goals by the Belgian Commission for the protection of privacy.

i

Self-employed persons constitute a small, but relevant, population in the construction industry (9% of manual workers), automotive industry (5% of manual workers; mainly in repair and maintenance work) and metal products manufacturing (3% of manual workers).

References

  • 1.Van den Borre L, Deboosere P. Asbestos in Belgium: an underestimated health risk. The evolution of mesothelioma mortality rates (1969–2009). Int J Occup Environ Health 2014;20:134–40. 10.1179/2049396714Y.0000000058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Weill H, Hughes J, Churg A. Changing trends in US mesothelioma incidence. Occup Environ Med 2004;61:438–41. 10.1136/oem.2003.010165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Virta RL. Worldwide asbestos supply and consumption trends from 1900 through 2003 Reston, VA: U.S. Department of the Interior; 2006, U.S. Geological Survey Report No.: Circular 1298. [Google Scholar]
  • 4.Vande Weyer R. Bilan de l'indemnisation de l'asbestose. Acta Tuberc Pneumol Belg 1973;64:304–51. [PubMed] [Google Scholar]
  • 5.Lacquet LM, van der Linden L, Lepoutre J. Roentgenographic lung changes, asbestosis and mortality in a Belgian asbestos-cement factory. In: Wagner JC, ed. Biological effects of mineral fibres IARC Scientific Publication 30. Lyon, France: International Agency for Research on Cancer, 1980:783–95. [PubMed] [Google Scholar]
  • 6.Nawrot T, Van Kersschaever G, Van Eycken E et al. Belgium: historical champion in asbestos consumption. Lancet 2007;369:1692 10.1016/S0140-6736(07)60776-4 [DOI] [PubMed] [Google Scholar]
  • 7.De Kezel E. Asbest, gezondheid en veiligheid. Ontwikkelingen in het aansprakelijkheidsrecht. Antwerpen: Intersentia, 2013. [Google Scholar]
  • 8.Nay SY. Asbestos in Belgium: use and abuse. Int J Occup Environ Health 2003;9:287–93. 10.1179/oeh.2003.9.3.287 [DOI] [PubMed] [Google Scholar]
  • 9.Van De Voorde H, Meulepas E, Gyselen A et al. Doodsoorzaken bij de bevolking woonachtig rond en bij de arbeiders werkzaam in een asbestverwerkende nijverheid in het noorden van Brabant. Acta Tuberc Pneumol Belg 1967;58:924–42. [PubMed] [Google Scholar]
  • 10.Vande Weyer R. Pathologie respiratoire de l'amiante en Belgique. Rev Méd Brux 1981;2:69–81. 10.1016/S0248-8663(81)80011-2 [DOI] [PubMed] [Google Scholar]
  • 11.International Agency for Research on Cancer. Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite, and anthophyllite). A review of human carcinogens Part C: Arsenic, metals, fibres, and dusts/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Vol. 100 Lyon, France: International Agency for Research on Cancer, 2012:219–309. [Google Scholar]
  • 12.Scientific Institute of Public Health, Public Health and Surveillance. Standardized procedures for mortality analysis. Brussels, 2015. http s://www.wiv-isp.be/epidemio/spma [Google Scholar]
  • 13.Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med 1999;56:505–13. http://oem.bmj.com/cgi/doi/10.1136/oem.56.8.505 10.1136/oem.56.8.505 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Rothman KJ, Boice JD. Epidemiological analysis with a programmable calculator. Washington DC: US Government Printing Office, 1979. [Google Scholar]
  • 15.Paustenbach DJ, Madl AK, Donovan E et al. Chrysotile asbestos exposure associated with removal of automobile exhaust systems (ca. 1945–1975) by mechanics: results of a simulation study. J Expo Sci Environ Epidemiol 2006;16:156–71. 10.1038/sj.jea.7500450 [DOI] [PubMed] [Google Scholar]
  • 16.Finkelstein MM. Asbestos fibre concentrations in the lungs of brake workers: another look. Ann Occup Hyg 2008; 52:455–61. 10.1093/annhyg/men036 [DOI] [PubMed] [Google Scholar]
  • 17.Ameille J, Rosenberg N, Matrat M et al. Asbestos-related diseases in automobile mechanics. Ann Occup Hyg 2012;56: 55–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lin S, Wang X, Yu ITS et al. Cause-specific mortality in relation to chrysotile-asbestos exposure in a Chinese cohort. J Thorac Oncol 2012;7:1109–14. [DOI] [PubMed] [Google Scholar]
  • 19.Pira E, Pelucchi C, Piolatto PG et al. First and subsequent asbestos exposures in relation to mesothelioma and lung cancer mortality. Br J Cancer 2007;97:1300–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hein MJ, Stayner LT, Lehman E et al. Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. Occup Environ Med 2007;64:616–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Fear NT, Roman E, Carpenter LM et al. Cancer in electrical workers: an analysis of cancer registrations in England, 1981–87. Br J Cancer 1996;73:935–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hashibe M, Brennan P, Chuang S et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the INHANCE Consortium. Cancer Epidemiol Biomarkers Prev 2009;18:541–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Paget-Bailly S, Cyr D, Luce D. Occupational exposures to asbestos, polycyclic aromatic hydrocarbons and solvents, and cancers of the oral cavity and pharynx: a quantitative literature review. Int Arch Occup Environ Health 2012;85:341–51. 10.1007/s00420-011-0683-y [DOI] [PubMed] [Google Scholar]
  • 24.Dement J, Welch L, Haile E et al. Mortality among sheet metal workers participating in a medical screening program. Am J Ind Med 2009;52:603–13. 10.1002/ajim.20725 [DOI] [PubMed] [Google Scholar]
  • 25.Ulvestad B, Kjærheim K, Martinsen JI et al. Cancer incidence among workers in the asbestos-cement producing industry in Norway. Scand J Work Environ Health 2002;28:411–17. 10.5271/sjweh.693 [DOI] [PubMed] [Google Scholar]
  • 26.Langevin SM, O'Sullivan MH, Valerio JL et al. Occupational asbestos exposure is associated with pharyngeal squamous cell carcinoma in men from the greater Boston area. Occup Environ Med 2013;70:858–63. 10.1136/oemed-2013-101528 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Koskinen K, Pukkala E, Reijula K et al. Incidence of cancer among the participants of the Finnish Asbestos Screening Campaign. Scand J Work Environ Health 2003;29:64–70. 10.5271/sjweh.706 [DOI] [PubMed] [Google Scholar]
  • 28.Raffn E, Lynge E, Juel K et al. Incidence of cancer and mortality among employees in the asbestos cement industry in Denmark. Br J Ind Med 1989;46:90–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Krstev S, Stewart P, Rusiecki J et al. Mortality among shipyard Coast Guard workers: a retrospective cohort study. Occup Environ Med 2007;64:651–8. 10.1136/oem.2006.029652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gustavsson P. Low-dose exposure to asbestos and lung cancer: dose-response relations and interaction with smoking in a population-based case-referent study in Stockholm, Sweden. Am J Epidemiol 2002;155:1016–22. 10.1093/aje/155.11.1016 [DOI] [PubMed] [Google Scholar]
  • 31.Markowitz SB, Levin SM, Miller A et al. Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. Am J Respir Crit Care Med 2013;188:90–6. 10.1164/rccm.201302-0257OC [DOI] [PubMed] [Google Scholar]
  • 32.Blanc PD, Iribarren C, Trupin L et al. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax 2009;64:6–12. 10.1136/thx.2008.099390 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Boffetta P, McLaughlin JK, la Vecchia C et al. “Environment” in cancer causation and etiological fraction: limitations and ambiguities. Carcinogenesis 2007;28:913–15. 10.1093/carcin/bgm034 [DOI] [PubMed] [Google Scholar]
  • 34.Mirabelli D, Cavone D, Merler E et al. Non-occupational exposure to asbestos and malignant mesothelioma in the Italian National Registry of Mesotheliomas. Occup Environ Med 2010;67:792–4. 10.1136/oem.2009.047019 [DOI] [PubMed] [Google Scholar]
  • 35.Starr P. Social categories and claims in the liberal state. In: Douglas M, Hull D, eds. How classification works. Edinburgh University Press, 1992:154–79. [Google Scholar]
  • 36.Pichault F, Xhauflair V, Deflandre D, et al. Flexibiliteit en Aantrekkelijkheid: Sociaal overleg in een context van projectmanagement. Report Federatie van Algemene Bouwondernemers-Fédération des Entrepreneurs Généraux de la Construction, 2005:103.

Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES